CHWY
Chewy, Inc.
CHWY has the edge over NIO overall, supported by stronger valuation and stronger modeled upside.
NIO
NIO Inc.
NIO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CHWY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
CHWY's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
CHWY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 22x | $22.60 | — |
| Current | 34x | $22.60 | — |
| Cheap | 37x | $24.73 | +9.4% |
| Fair | 94x | $62.06 | +175% |
| Expensive | 623x | $411 | +1720% |
Historical ranges are pointers, not guarantees.
CHWY's PE is in its cheap range at 34x. If earnings grow as analysts expect, today's price would be 22x next year's earnings.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
CHWY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for CHWY, with profitability improving.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
CHWY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.02 | +54% |
| Q3 2026 | $0.66 | +78% |
| Q2 2026 | $0.60 | -34% |
| Q1 2026 | $0.52 | -43% |
| Q4 2025 | $0.50 | -46% |
| Q3 2025 | $0.37 | -55% |
| Q2 2025 | $0.91 | +379% |
| Q1 2025 | $0.91 | +911% |
| Q4 2024 | $0.92 | +2967% |
CHWY has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
CHWY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +7.3% |
| Q2 2026 | $3.4B | +7.7% |
| Q1 2026 | $3.3B | +0.5% |
| Q4 2025 | $3.1B | +8.3% |
| Q3 2025 | $3.1B | +8.6% |
| Q2 2025 | $3.1B | +8.3% |
| Q1 2025 | $3.2B | +14% |
| Q4 2024 | $2.9B | +5.1% |
CHWY's revenue has grown year over year every quarter since late 2020: $3.3B last quarter, up 7.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.8% | +0.5 points |
| Q2 2026 | 3.8% | +1.4 points |
| Q1 2026 | 1.3% | +1.6 points |
| Q4 2025 | 2.1% | +1.2 points |
| Q3 2025 | 2.3% | +1.1 points |
| Q2 2025 | 2.5% | +0.2 points |
| Q1 2025 | -0.3% | +0.4 points |
| Q4 2024 | 0.9% | +1.3 points |
CHWY has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
CHWY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $89.5M | -15% |
| Q2 2026 | $70.8M | +45% |
| Q1 2026 | $232M | +48% |
| Q4 2025 | $175.8M | +16% |
| Q3 2025 | $105.9M | +16% |
| Q2 2025 | $48.7M | -7.5% |
| Q1 2025 | $156.6M | +136% |
| Q4 2024 | $151.8M | +213% |
CHWY has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
CHWY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -2.6x | Net Cash |
| Q4 2024 | -2.4x | Net Cash |
CHWY has more cash than debt.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CHWY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 58.6 | Neutral |
CHWY's weekly RSI is 51 (neutral) and its Stochastic is 59 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
CHWY PE vs Consumer Cyclical Sector
| Metric | CHWY | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 18x | 90% above |
| PE % | 7 | 47 | 40 pts below |
CHWY is trading at 34x earnings, a 90% premium to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
CHWY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.6 | 9.8% above |
| 20 week MA | $21.4 | 5.4% above |
| 50 week MA | $24.4 | 7.5% below |
| 100 week MA | $31.0 | 27% below |
| 200 week MA | $29.0 | 22% below |
CHWY has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
CHWY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.6 | $104.0 | +263% |
| 2021 | $104.0 | $59.3 | -43% |
| 2022 | $59.3 | $39.3 | -34% |
| 2023 | $39.3 | $23.6 | -40% |
| 2024 | $23.6 | $34.1 | +44% |
| 2025 | $34.1 | $32.5 | -4.6% |
| 2026 YTD | $32.5 | $22.6 | -30% |
CHWY has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.